AblaCare
Hugh Magen has a long history of working in research and design engineering, starting with their role as an R&D Engineer for US Surgical (Vascular Therapies) in 1998. Hugh then moved to Progressive Angioplasty Systems in the same year, where they held the same position. In 1999, they took a role as an R&D Project Engineer at Stellartech Research. In 2002, they became a Senior Project Engineer at Coapt Systems. In 2005, they were a Senior Director of R&D at Rubicor Medical. From 2008 to 2010, they worked as a Medical Device R&D Engineering Consultant (self-employed). From 2010 to 2012, they were a Vice President of R&D at AEGEA Medical, Inc. In 2021, they became the Chief Technology Officer at May Health and the Vice President of R&D (AEGEA) at CooperSurgical.
Hugh Magen received a MS in Biomedical Engineering from the University of California, Davis between 1995 and 1997. Hugh also received a BS in Aerospace Engineering from the University of Virginia between 1986 and 1990.
This person is not in any offices
AblaCare
AblaCare develops an innovative solution for Polycystic Ovary Syndrome (PCOS) related infertility.